# OnCo record nct04447235 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04447235/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04447235", "NCT04447235" ;
  schema:name "Ivermectin plus losartan for COVID-19 in cancer patients (ICESP phase 2, terminated)"@en ;
  schema:description "This Brazilian trial tested ivermectin against COVID-19 in people with cancer, not against the cancer itself. It was stopped early because an interim analysis found no difference between the drug and placebo."@en ;
  schema:url <https://onco.cc/trials/nct04447235/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04447235> ;
  onco:status "negative" ;
  onco:phase "2" ;
  onco:drugs <https://onco.cc/drugs/ivermectin/> ;
  onco:institutions <https://onco.cc/institutions/icesp/> ;
  onco:terms <https://onco.cc/terms/futility/> .